Back

Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Covid-19 and heart failure Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Maria Bergami

University Hospital of Bologna S. Orsola-Malpighi Polyclinic, Bologna (Italy)

7 More presentations in this session

Presentation thumbnail
Risk of worsening heart failure and all-cause mortality following mRNA covid-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study
Ms C. Sindet-Pedersen (Hellerup, DK)
Abstract Slides
Presentation thumbnail
Monitoring of the lung fluid status in hospitalized COVID-19 patients for predicts outcome. Results of the IMPEDANCE-Corona Trial
Professor M. Kleiner Shochat (Hadera, IL)
Abstract Slides
Presentation thumbnail
Factors of persistent limited exercise tolerance in patients after COVID-19 with normal left ventricular ejection fraction
Miss K. Gryglewska-Wawrzak (Lodz, PL)
Abstract Slides
Presentation thumbnail
The impact of pre-existing chronic heart failure on the intensive care treatment and outcome of old intensive care patients suffering from COVID-19
Doctor R. Bruno (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
History of heart failure and chronic kidney disease and the risk for all-cause death after COVID-19 during the three first waves in comparison to influenza outbreaks in Sweden.
Doctor V. Ritsinger (Stockholm, SE)
Abstract Slides

Access the full session

Session thumbnail
Covid-19 and heart failure

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Session
From genetic signatures to clinical implications
thumbnail
Congress Presentation
Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources